Growth hormone stimulates the degradation of calcium phosphate biomaterial by human monocytes macrophages in vitro

Journal of Biomedical Materials Research

Volumn 40, Issue 1, 1998, Pages 79-85

  Guicheux, Jérôme ^a   Kimakhe, Saïd ^a   Heymann, Dominique ^a   Pilet, Paul ^a   Daculsi, Guy ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Biphasic calcium phosphate; Cell degradation; Growth hormone; Lipopolysaccharides; Monocyte

Indexed keywords

ANIMAL CELL CULTURE; BIODEGRADATION; CERAMIC MATERIALS; HORMONES; PHOSPHATE MINERALS; POLYSACCHARIDES;

CALCIUM PHOSPHATE; MONOCYTES;

IMPLANTS (SURGICAL);

CALCIUM PHOSPHATE; HUMAN GROWTH HORMONE; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE;

BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELLS, CULTURED; HUMAN GROWTH HORMONE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES;

EID: 0032053420     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199804)40:1<79::AID-JBM9>3.0.CO;2-O     Document Type: Article

References (39)

1. N. Passuti, G. Daculsi, J. M. Rogez, S. Martin, and J. V. Bainvel, "Macroporous calcium phosphate ceramic performance in human spine fusion," Clin. Orthop. Relat. Res., 248, 12-19 (1989).
2. G. Daculsi, N. Passuti, S. Martin, C. Deudon, R. Z. Legeros, and S. Raher, "Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study," J. Biomed. Mater. Res., 24, 379-396 (1990).
3. P. K. Bajpai and H. A. Benghuzzi, "Ceramic systems for long-term delivery of chemicals and biologicals," J. Biomed. Mater. Res., 22, 1245-1266 (1988).
4. K. De Groot, "Bioceramics of calcium phosphate," CRC Press, Boca Raton, Florida, 1983.
5. M. Jarcho, "Calcium phosphate as hard tissue prosthetics," Clin. Orthop. Relat. Res., 157, 259-279 (1981).
6. J. Guicheux, G. Grimandi, M. Trecant, A. Faivre, S. Takahashi, and G. Daculsi, "Apatite as carrier for growth hormone: In vitro characterization of loading and release," J. Biomed. Mater. Res., 34, 165-170 (1997).
7. J. Guicheux, D. Heymann, M. Trecant, H. Gautier, A. Faivre, and G. Daculsi, "Association of human growth hormone and calcium phosphate by dynamic compaction: In vitro biocompatibility and bioactiviry," J. Biomed. Mater. Res., 36, 258-264 (1997).
8. G. Daculsi, "Physicochemical and ultrastructural analysis of bone bioactive interface," Biomater. Tiss. Int., 10, 296-304 (1992).
9. R. Z. Legeros, "Biodegradation and bioresorption of calcium phosphate ceramics," Clin. Mater., 14, 65-88 (1983).
10. H. M. Blottière, G. Daculsi, I. Anegon, J. A. Pouëzat, P. N. Nelson, and N. Passutti, "Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphate," Biomaterials, 16, 497-503 (1995).
11. M. Benahmed, J. M. Bouler, D. Heymann, O. Gan, and G. Daculsi, "Biodegradation of synthetic biphasic calcium phosphate by human monocytes in vitro: A morphological study," Biomaterials, 17, 2173-2178 (1996).
12. M. Benahmed, H. Blottière, V. Praloran, and G. Daculsi, "Monocyte activity in the presence of calcium phosphate acti-vated by 1,25 (OH)2 VD3 and interferon," Biomaterials, 15, 25-30 (1994).
13. M. Benahmed, D. Heymann, M. Berreur, M. Cottrel, A. Godard, G. Daculsi, and G. Pradal, "Ultrastructural study of degradation of calcium phosphate ceramic by human monocytes and modulation of this activity by HILDA/LIF cytokine," J. Histochem. Cytochem., 44, 1131-1140 (1996).
14. M. Benahmed, D. Heymann, P. Pillet, J. Bienvenu, and G. Daculsi, "LPS increases biomaterial degradation by monocytes in vitro," J. Biomed. Mater. Res., 34, 115-119 (1996).
15. R. Barnard, K. W. Ng, T. J. Martin, and M. J. Waters, "Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH," Endocrinology, 128, 1459-1464 (1991).
16. M. Kassem, W. Blum, J. Ristelli, L. Mosekilde, and E. F. Eriksenl, "Growth hormone stimulates proliferation and differentiation of stromal human osteoblast-like cells in vitro," Calcif. Tiss. Int., 52, 222-226 (1993).
17. O. Isaksson, J. O. Jansson, and I. A. M. Gause, "Growth hormone stimulates longitudinal bone growth directly,Science, 216, 1237-1239 (1982).
18. K. Nishiyama, T. Sugimoto, H. Kaji, M. Kanati, T. Kobayashi, and K. Chihara, "Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation," Endocrinology, 137, 35-41 (1996).
19. K. W. Kelley, "The role of growth hormone in modulation of the immune response," Ann. NY Acad. Sci., 594, 95-103 (1990).
20. S. Merchav, I. Tatarsky, and Z. Hochberg, "Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor 1/somatomedin C and human growth hormone," J. Clin. Invest., 81, 791-797 (1988).
21. W. Kiess and O. Butenandt, "Specific growth hormone receptors on human peripheral mononuclear cells: Reexpression, identification and characterization," J. Clin. Endocrin. Metab., 60, 740-756 (1985).
22. P. Jafari and D. N. Khansari, "Detection of somatotropin receptors on human monocytes," Immunol. Lett., 24, 199-202 (1990).
23. R. R. Gala, "Prolactin and growth hormone in the regulation of the immune system," Proc. Soc. Exp. Biol. Med., 198, 513-527 (1991).
24. H. Saito, T. Inoue, and K. Fukatsu, "Growth hormone and the immune response to bacterial infection," Harm. Res., 45, 50-54 (1996).
25. J. Warwick-Davies, D. B. Lowrie, and P. J. Cole, "Growth hormone is a human macrophage-activating factor. Priming of human monocytes for enhanced release of H2O2," J. Immunol., 154, 1909-1918 (1995).
26. C. K. Edwards, S. M. Ghiasuddin, J. M. Schepper, L. M. Yunger, and K. W. Kelley, "A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion," Science, 239, 769-771 (1987).
27. C. K. Edwards, S. M. Ghiasuddin, L. M. Yunger, R. M. Lorence, S. Arkins, R, Dantzer, and K. W. Kelley, "In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: Enhanced resistance to experimental Salmonella typhimrium infection is correlated with generation of reactive oxygen intermediates," Infect. Immun., 60, 2514-2521 (1992).
28. T. Inoue, H. Saito, R. Fukushima, K. Fukatsu, M. T. Lin, T. Inaba, and T. Muto, "Effects of growth hormone and insulinlike growth factor 1 on the activation of phagocytic cells and systemic cytokine production in a mice sepsis model," Clin. Nutr., 12 (suppl.), S16 (1994).
29. G. Wei, Y. Kotoura, M. Oka, T. Yamamuro, R. Wada, S.-H. Hyon, and Y. Ikada, "Biocompatible delivery system for antibiotic treatment of osteomyelitis,J. Bone Joint Surg., 73, 246-253 (1991).
30. Y. Shinto, A. Uchida, F. Korkusuk, N. Araki, and K. Ono, "Calcium hydroxyapatite ceramic used as a delivery system for antibiotics," J. Bone Joint Surg., 74, 600-604 (1992).
31. M. Otsuka, Y. Matsuda, Y. Suwa, J. L. Fox, and W. I. Higuchi, "A novel skeletal drug delivery system using self-setting calcium phosphate cement. Physicochemical properties and drug release rate of the cement-containing indomethacin," J. Pharmaceutic. Sci, 83, 611-615 (1994).
32. H. Denissen, E. Van Beek, C. Lowick, S. Papapoulos, and A. Van den Hoof, "Ceramic hydroxyapatite implants for the release of biphosphonate," Bone and Miner., 25, 123-134 (1993).
33. T. H. Nguyen, M. Cromwell, R. Wong, L. S. Beck, P. Plouhar, and B. Ongpipattatanskul, "Artificial bone graft formulation for rhTGF-β1," Proc. Int. Symp. Control. Rel. Bioact. Mater., 21, 122-124 (1994).
34. S. Dowries, L. Di Silvio, R. S. Archer, and M. V. Kayser, "Growth hormone loaded biomaterials: Their ability to stimulate osteoid formation at the bone-material interface," in Bone Bonding, C. A. Van Blitterswijk (ed.), Reed Healthcare Communications, Leiden, The Netherlands, 1992, pp. 101-109.
35. S. M. Russel and E. M. Spencer, "Local injection of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats," Endocrinology, 116, 2563-2567 (1985).
36. S. Downes, L. Di Silvio, C. P. A. T. Klein, and M. V. Kayser, "Growth-hormone-loaded bioactive ceramics," J. Mater. Sci. Mater. Med., 2, 176-180 (1991).
37. R. A. Lindemann and F. Eilber, "Activation of human natural killer cells by lipopolysaccharide from Actinobacillus actinomycetemcomitans," Arch. Oral Biol., 34, 459-463 (1989).
38. S. Agarwal, C. Baran, N. P. Piesco, J. C. Quintero, H. H. Langkamp, L. P. Johns, and C. S. Chandra, "Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1β," J. Periodont. Res., 30, 382-389 (1995).
39. R. A. Lindemann, J. S. Economou, and H. Rothermel, "Production of interleukin-1 and tumor necrosis factor by human peripheral monocytes activated by periodontal bacteria and extracted lipopolysaccharides," J. Dent. Res., 67, 1131-1135 (1988).